Terzepatide

1 2

This product is intended exclusively for laboratory research and in vitro studies conducted by qualified professionals. It is not approved for use in humans or animals. Any misuse, mislabeling, or representation as a drug, food, or cosmetic is strictly prohibited. All content provided is for informational and educational purposes only.

Terzepatide

Terzepatide

$48.00
$60.00 $48.00
Sale Sold out
Tirzepatide – Dual Incretin Research Peptide (GLP-1/GIP Agonist) Tirzepatide is a novel synthetic peptide that acts as a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent...
Read More
Read Less
Buy 3+ for $ each and save 2%
Buy 5+ for $ each and save 4%
Buy 10+ for $ each and save 6%
Ships Today if ordered within 10 hrs 5 min.
Free international delivery within 1-3 business days on orders over $600, with a tracking number provided.
Third party tested
img

FREE Bacteriostatic Water

For every $400 you spend, get 1 FREE bottle of Bacteriostatic Water to reconstitute your peptides.

View full details

Characteristics

Benefits

Summary

Certificate of Analysis (COA)

Characteristics

  • Molecular Formula
  • C225H348N60068

  • CAS Number
  • 2023788-19-2

  • Molar Mass
  • 5047.61 g/mol

  • Amino Acid Sequence
  • His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-lle-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly

  • Synonyms
  • LY3298176

  • Solubility
  • Water-soluble

  • Composition
  • White to off-white powder, requires reconstitution

Benefits

Glycemic Control

Multiple clinical trials have investigated Tirzepatide's effects on glycemic control in individuals with type 2 diabetes:

  • Significant reductions in HbA1c levels compared to placebo and active comparators
  • Improvements in fasting and postprandial glucose levels

Weight Management

Studies have examined Tirzepatide's impact on body weight:

  • Substantial weight loss observed in individuals with obesity or overweight
  • Weight loss effects appear to be dose-dependent

Cardiovascular Effects

Research has explored potential cardiovascular impacts:

  • Improvements in lipid profiles, including reductions in triglycerides and LDL cholesterol
  • Modest reductions in blood pressure observed in some studies

Renal Function

Limited data suggest potential renal effects:

  • Reductions in albuminuria reported in some trials
  • Long-term effects on kidney function require further investigation

Summary

Tirzepatide represents a novel approach in the treatment of type 2 diabetes and obesity, leveraging dual activation of GIP and GLP-1 receptors. Clinical research has demonstrated its efficacy in improving glycemic control and promoting weight loss. While showing promise, long-term studies are needed to fully elucidate its effects on cardiovascular and renal outcomes.

Certificate of Analysis (COA)

img
img

Your Reliable source for high-quality research peptides

img

Transparent Pricing

Fair prices without industry markups or gimmicks

img

Verified Quality

Every batch independently tested for purity and consistency

img

Fast Order Turnrounds

Orders often ship same day